Related Experiment Videos
Medulloblastoma/primitive neuroectodermal tumor in 45 adults
1Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY.
Neurology
|March 1, 1995
Summary
Adult medulloblastoma/primitive neuroectodermal tumors (PNET) often recur, with most cases showing central nervous system (CNS) dissemination or metastasis. Long-term follow-up is crucial for detecting late recurrences in these uncommon adult brain tumors.
Area of Science:
- Neuro-oncology
- Pediatric and Adult Brain Tumors
- Medical Oncology
Background:
- Medulloblastoma/primitive neuroectodermal tumors (PNET) are rare in adults, presenting unique clinical challenges.
- Understanding adult PNET presentation and treatment response is essential for improving outcomes.
Purpose of the Study:
- To review the clinical characteristics, treatment outcomes, and recurrence patterns of medulloblastoma/PNET in adult patients.
- To evaluate the efficacy of standard treatment protocols in the adult population.
Main Methods:
- Retrospective review of medical records for 45 adult patients (≥15 years) diagnosed with medulloblastoma/PNET.
- Analysis of presenting symptoms, diagnostic findings, treatment modalities (surgery, radiation, chemotherapy), and follow-up data.
- Categorization of recurrence patterns, including local, CNS dissemination, and systemic metastasis.
Main Results:
- Most adult patients presented with posterior fossa tumors.
- Despite initial response to multimodal therapy, approximately 50% of patients experienced recurrence.
- Recurrences were predominantly CNS dissemination or systemic metastasis, rather than local relapse.
Conclusions:
- Adult medulloblastoma/PNET requires treatment strategies similar to those used in pediatric patients.
- The high rate of non-local recurrence underscores the need for comprehensive staging and surveillance.
- Long-term follow-up is critical for identifying late and distant recurrences in adult PNET survivors.